SOPHARMA AD: Current report 121 Romfarm 13.53% 10092013 ENG

opublikowano: 2013-09-10 14:03

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załączników:
Current_report_121_Romfarm_13.53%_10092013_ENG.doc  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 121 / 2013
Date of issue: 2013-09-10
Short name of the issuer
SOPHARMA AD
Subject
Current report 121 Romfarm 13.53% 10092013 ENG
Official market - legal basis
Art. 70 pkt 1 Ustawy o ofercie - nabycie lub zbycie znacznego pakietu akcji
Unofficial market - legal basis
Contents of the report:
NOTIFICATION


Sopharma AD (the “Company") announces that on 10 September 2013 the Company received a notification for the acquisition of 11,885,951 shares, representing 9% of its capital, by Rompharm Company OOD. After the transaction the share of Rompharm Company OOD in the capital of Sopharma AD reached 13.53%.
Annexes
File Description
Current report 121 Romfarm 13.53% 10092013 ENG.docCurrent report 121 Romfarm 13.53% 10092013 ENG.doc Current report 121 Romfarm 13.53% 10092013 ENG

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2013-09-10 Ognian Donev Executive director